Plasma tissue factor is a predictor for restenosis after femoropopliteal angioplasty

British Journal of Surgery

Volumn 94, Issue 9, 2007, Pages 1092-1095

  Ray, B ^a   Chetter, I C ^a,b   Lee, H L D ^a   Ettelaie, C ^a   McCollum, P T ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOPLASTIN;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CLAUDICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEMOROPOPLITEAL BYPASS; HUMAN; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANK SUM TEST; RESTENOSIS; TISSUE BLOOD FLOW; BLOOD; CASE CONTROL STUDY; FEMORAL ARTERY; INTERMITTENT CLAUDICATION; METABOLISM; MIDDLE AGED; POPLITEAL ARTERY; PROSPECTIVE STUDY; RECURRENT DISEASE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; CASE-CONTROL STUDIES; FEMALE; FEMORAL ARTERY; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; POPLITEAL ARTERY; PROSPECTIVE STUDIES; RECURRENCE; THROMBOPLASTIN; TREATMENT OUTCOME;

EID: 35448985000     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5759     Document Type: Article

References (16)

1. Gutridge B, Torrie P, Galland B. Trends in arterial reconstruction, angioplasty and amputation. Health Trends 1994; 26: 88-91.
2. Cumberland DC. Percutaneous transluminal angioplasty: a review. Clin Radiol 1983; 34: 25-38.
3. Waltman AC, Greenfield AJ, Novelline RA, Abbott WM, Brewster DC, Darling RC et al. Transluminal angioplasty of the iliac and femoropopliteal arteries. Current status. Arch Surg 1982; 117: 1218-1221.
4. Minar E, Ahmadi A, Koppensteiner R, Maca T, Stumpflen A, Ururluoglu A et al. Comparison of effects of high-dose and low-dose aspirin on restenosis after femoropopliteal percutaneous transluminal angioplasty. Circulation 1995; 91: 2167-2173.
5. Siegbahn A. Cellular consequences upon factor VIIa binding to tissue factor. Haemostasis 2000; 30(Suppl 2): 41-47.
6. Kirchhofer D, Nemerson Y. Initiation of blood coagulation: the tissue factor/factor VIIa complex. Curr Opin Biotcchnol 1996; 7: 386-391.
7. Mizuno O, Ikeda U, Hojo Y, Fujikawa H, Katsuki T, Shimada K. Tissue factor expression in coronary circulation as a prognostic factor for late restenosis after coronary angioplasty. Cardiology 2001; 95: 84-89.
8. Tutar E, Ozcan M, Kilickap M, Gulec S, Aras O, Pamir G et al. Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation. Circulation 2003; 108: 1581-1584.
9. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 2000; 31: S1-S296.
10. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997; 26: 517-538.
11. Moons AH, Levi M, Peters RJ. Tissue factor and coronary artery disease. Cardiovasc Res 2002; 53: 313-325.
12. Koyama T, Nishida K, Ohdama S, Sawado M, Murakami N, Hirosawa S et al. Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol 1994; 87: 343.
13. Abrecht S, Kotzsch M, Siegert G, Luther T, Grossman H, Grosser M et al. Detection of circulating tissue factor and factor VII in a normal population. Thromb Haemost 1996; 75: 772-777.
14. Sambola A, Osende J, Hathcock J, Degen M, Nemerson Y, Fuster V et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 2003; 107: 973-977.
15. Marcucci R, Prisco D, Brunelli T, Pepe G, Gori AM, Fedi S et al. Tissue factor and homocysteine levels in ischemic heart disease are associated with angiographically documented clinical recurrences after coronary angioplasty. Thromb Haemost 2000; 83: 826-832.
16. Wahlgren CM, Sten-Linder M, Egberg N, Kalin B, Blohme L, Swedenborg J. The role of coagulation and inflammation after angioplasty in patients with peripheral arterial disease. Cardiovasc Intervent Radiol 2006; 29: 530-535.